August 20, 2014

GE Healthcare Life Sciences to Create New U.S. Headquarters in Massachusetts

  • When fully operational, new facility will house  more than 500 highly skilled employees and  bring more than 220 new jobs to Massachusetts
  • Long-term investment places new US business headquarters at the heart of the most dynamic and growing life sciences, healthcare and biotech cluster in the US
  • Furthers GE Healthcare Life Sciences’ leadership in molecular and precision medicine, clinical diagnostics, manufacturing and R&D
August 12, 2014

EMD Serono, Inc. Opens New Building in Billerica, Massachusetts

EMD Serono, Inc., an affiliate of Merck KGaA, announced the official site opening of their new Sagamore Building in Billerica, Massachusetts, and the dedication of the Bridge to Patients.  The Sagamore Building is a renovated facility designed to foster exploration and creativity, improve interactions between colleagues and enable a culture of possibilities. EMD Serono, Inc. and Merck KGaA executives, directors and employees celebrated the announcement at a ribbon-cutting ceremony with government officials from Massachusetts, and leaders of the Massachusetts life sciences industry.

Final - 2

Susan Windham-Bannister, Ph.D. President & CEO of the Massachusetts Life Sciences Center; John Tierney, U.S. Representative, 6th District of Massachusetts; Frank Stangenberg-Haverkamp, Ph.D. Merck family member and Chairman Executive Board of E. Merck KG; Paris Panayiotopoulos, President and Marketing Director, EMD Serono; Luciano Rossetti, MD. Executive Vice President, Global Head of Research & Development, Merck Serono; and Robert K. Coughlin, President & CEO of MassBio celebrate the dedication of EMD Serono’s new Sagamore Building and Bridge to Patients in Billerica.

August 5, 2014

Andrew Alliance Secures Series B Financing to Boost Growth of Life Science Co-worker Robot

Andrew Alliance announced today that the Company will be opening up a Boston office in Copley Square. The Company also announced the closing of a series B financing round from Omega Funds, a leading global healthcare fund specializing in late stage life science investments. The Omega investment will enable Andrew Alliance to expand the reach of its well-received robots, by enabling new developments and the establishment of commercial operations in the U.S. market.

Read the press release here »

July 28, 2014

Massachusetts Life Sciences Center Announces 2014 – 2015 Solicitation for Capital Projects

The Massachusetts Life Sciences Center (MLSC) announced today the launch of the fourth round of an open solicitation for life-sciences-related capital projects. The solicitation covers capital projects for academic/research institutions (including two- and four-year colleges), business incubators and other not-for-profit organizations in the Commonwealth. The MLSC will invest in high-potential economic development projects across the state that promise to create jobs and make a significant contribution to the state’s life sciences ecosystem. The MLSC has allocated up to $35 million in capital dollars for this solicitation.

Read the press release here »

July 22, 2014

Massachusetts Life Sciences Center Announces Opening of 2014 Life Sciences Tax Incentive Program

The Massachusetts Life Sciences Center announced today that applications are now being accepted for the 2014 Life Sciences Tax Incentive Program. All applications are due by 12:00 p.m. ET on Thursday, October 23, 2014 and can be submitted online.

The Program offers tax incentives to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. The Life Sciences Initiative authorizes the Center to award up to $25 million in tax incentives each year. Through five prior rounds the Center has awarded more than $115 million to growing companies across the state that have created thousands of jobs as a result.

To learn more about the program, register for information sessions, or apply, click here

Read the press release here »

July 15, 2014

Massachusetts Life Sciences Center Welcomes New Member to Corporate Consortium

The Massachusetts Life Sciences Center (MLSC) announced today that Roche has joined the Center’s Corporate Consortium Program, contributing funding to support MLSC investments in promising early stage companies.

Under the newly announced partnership, Roche, via their “Extending the Innovation Network” program aimed at discovering and creating opportunities in academia and biotech, will contribute funds to help support Massachusetts’ commitment to grow and retain early-stage life sciences companies.

Read the press release here »

July 14, 2014

A Request for Proposal for an Executive Search Firm has been Released by the MLSC

The Massachusetts Life Sciences Center has released a Request for Proposal (RFP) for an Executive Search Firm to recruit candidates for the position of President and Chief Executive Officer of the Center.

To access the RFP, please click here.

To access the Answers to Questions, please click here.

July 9, 2014

2011 MLSC Accelerator Company AesRx Repays Loan Early After Acquisition

The Massachusetts Life Sciences Center (MLSC) announced today that Newton-based AesRx, an Accelerator company awarded $750,000 in loan financing by the MLSC in 2011, has paid back its loan early after being acquired by Baxter International Inc., a diversified healthcare company based in Deerfield, IL. The company’s repayment amount (including investment proceeds) totaled $1,024,000. The acquisition was announced today in press releases issued by Baxter and the National Institutes of Health.

Read the press release here »

July 1, 2014

Massachusetts Life Sciences Center Announces Next Round of Life Sciences Accelerator Loan Program

The Massachusetts Life Sciences Center (MLSC), announced the launch of the tenth round of its Accelerator Loan Program, the MLSC’s flagship investment program that provides working capital to early-stage life sciences companies. The MLSC is now accepting applications for this program, due by 12:00 p.m. EDT August 4, 2014, on the MLSC’s web site at www.masslifesciences.com.

Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences ecosystem. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Deval Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008.

For more information about the Accelerator Program, and to apply, click here.

Read the press release here »

June 24, 2014

Governor Patrick, Massachusetts Life Sciences Center Announce New International Program to Promote Collaboration

Governor Deval Patrick today joined officials from the Massachusetts Life Sciences Center (MLSC) at the 2014 BIO International Convention to announce the launch of the Universal Partnerships (UP) Program, a new international program to provide grant funding to support Massachusetts companies who are forming R&D collaborations with life science organizations throughout the world. The creation of the UP Program furthers the Patrick Administration’s efforts to create global partnerships between life science organizations to enable scientific and commercial breakthroughs and to fuel economic development in the Commonwealth. The UP program enhances the MLSC’s international program portfolio by offering Massachusetts more collaboration opportunities.

Read the press release here »

June 23, 2014

2012 MLSC Accelerator company Sample6 repays loan early after successful round of fundraising

The Massachusetts Life Sciences Center (MLSC) announced that Boston-based Sample6, an Accelerator company awarded $750,000 by the MLSC in 2012, has paid back its loan early after successfully raising $11 million in its Series B financing round.  The company’s repayment totaled $884,898.

Sample6 Repayment2

Michael Koeris, Co-founder, and Vice President, Business Development & Operations for Sample6, Susan Windham-Bannister, Ph.D. President & CEO of the Massachusetts Life Sciences Center, Governor Deval Patrick, Shana Cooper, Director of Product Management for Sample6 and Senate President, Therese Murray celebrate Sample6’s repayment to the MLSC.

Read the press release here »

June 18, 2014

New Research Confirms Governor Patrick’s Life Sciences Initiative is Driving Job Creation and Economic Opportunity

Northeastern University’s Kitty and Michael Dukakis Center for Urban and Regional Policy released new data detailing the growth of the life sciences sectors in Massachusetts, demonstrating the importance of these sectors to the Massachusetts economy and the importance of continued investment in life sciences growth.

The new research shows that Massachusetts ranks number 1 per capita in the nation in total life sciences employment by a wide margin, with 1.8 times the number of jobs per-capita as California, and 2.3 times the number in New York. The report also found that the industry sectors targeted for investment by the Massachusetts Life Sciences Center have been growing rapidly, with 17.5% growth since 2006, compared to 1.4% job growth in the overall state economy.

View the release from The Dukakis Center by clicking here

View the release from the MLSC here

To view the presentation report, please click here

June 12, 2014

Massachusetts Life Sciences Center announces 2014 – 2015 solicitation for the STEM Equipment and Supplies Grant Program

The Massachusetts Life Sciences Center (MLSC) announced the launch of the fourth round of an open solicitation for capital grants for public schools for the purchase of life sciences-related equipment and supplies. This year, for the first time, both high schools and middle schools are invited to apply for funding.

For more information on the program, click here

Read the press release here »

June 12, 2014

MBL International and Scivax USA Open their First U.S. R&D Laboratory in Woburn, MA

MBL International Corporation and SCIVAX USA, INC. announced the official opening of a new shared laboratory in Woburn, Massachusetts, an emerging life science innovation district in the Greater Boston area. MBL International Corporation and SCIVAX USA, INC. hosted a ribbon-cutting ceremony to mark the opening of their new facility. A number of industry and government officials participated, including the Consul General of Japan in Boston.

The 3,000 square-foot immunological and molecular biological R&D facility houses both MBL International and SCIVAX USA’s state-of-the art imaging equipment, including a GE InCell2200 and Flow Cytometer. In addition to imaging instrumentation, the facility is outfitted with a cell culture capability focused on novel three-dimensional cell culture technology.

DSCN9706

(left) Kimimasa Yamada, CEO of MBL International Corporation and Hiromi Miura (right), President of SCIVAX USA hold the ribbon as Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center (MLSC) cuts it to mark the grand opening of the new lab facility

Read the press release here »

June 12, 2014

Moderna Announces Expansion to New Facility in Kendall Square

Moderna Therapeutics announced the company’s expansion to 320 Bent Street in the Kendall Square area of Cambridge, a move that adds nearly 50,000 square feet of office, laboratory and manufacturing facilities to Moderna’s operations in Massachusetts.

DSCN9667

Read the press release here »

Connect With Us

Facebook LinkedIn Twitter